Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 2p13 2 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Genomic change | Small missing segment at 2p13.2 | Duplicated material at 11p15.4 | High |
| Reported severity | Source severity labeled severe, but features vary by genes | Source severity labeled moderate, with varied developmental features | Moderate |
| Onset documentation | Recorded onset range 0-0, consistent with congenital recognition | Onset listed as 0-null and is not established | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Testing identifies a 2p13.2 deletion
The defining abnormality is loss, not gain, of chromosomal material
High
Care planning uses the supplied severity label
The source classifies this condition as severe, while emphasizing variable features
Moderate
Congenital presentation is documented
The supplied onset supports recognition from birth, without defining symptoms
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
Testing identifies an 11p15.4 duplication
The defining abnormality is duplicated chromosome 11 material
High
Developmental features require individualized assessment
The source describes varied features rather than a fixed syndrome picture
Moderate
Severity appears less extensive than the comparator
The supplied label is moderate, but this does not predict an individual course
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss at 2p13.2 | Copy-number gain at 11p15.4 | Location and loss versus gain distinguish the findings; clinician review is required |
| Conventional karyotype | May miss a small deletion | May miss a small duplication | A normal karyotype does not exclude either micro-level change |
| Parental genetic studies | May clarify inheritance when available | May clarify inheritance when available | Results aid counseling but do not establish prognosis from these sources |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source only labels severity as severe.
- Factors
- Affected genes, confirmed deletion, and individual clinical findings.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Long-term outcome is not established; the source only labels severity as moderate.
- Factors
- Affected genes, confirmed duplication, and developmental assessment.
Time frame: Both are chronic congenital conditions; no reliable timeline is supplied.
No prevalence, mortality, or treatment-response data should be inferred.
Complications comparison
| Complication | Presentation |
|---|---|
| Specific complications | Not established in the supplied data Not established in the supplied data Do not infer organ, developmental, or mortality complications without clinical evidence |
| Support needs | May be greater because severity is labeled severe May be less extensive under the moderate label Needs still depend on the genes affected and individual assessment |
| Course | Described as chronic Described as chronic Both are long-term congenital conditions, but their courses are not identical |
Patient education highlights
- HighResult versus diagnosis
An abnormal chromosomal result requires specialist interpretation and does not by itself define every symptom.
- HighIndividual variation
Features depend on the affected genes and can differ between people with the same region involved.
- MediumInheritance counseling
Neither condition is communicable; a genetics professional can discuss recurrence and family testing.